Global Joint Pain Injection Market, 2021-2027

February 2022 | 78 pages | ID: GBDF3D3E3E98EN
Gen Consulting Company

Abstracts

Joint pain is a very common problem with many possible causes, but it's usually a result of injury or arthritis. In older people, joint pain that gets steadily worse is usually a sign of osteoarthritis. Projected to expand at a CAGR of 7.7% from 2021 to 2027, the global joint pain injection market will worth USD 5,135 million by 2027-end, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global joint pain injection market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The joint pain injection market is segmented on the basis of injection type, joint type, distribution channel, and region. The joint pain injection market is segmented as below:

By injection type:

• corticosteroid
• hyaluronic acid
• others

By joint type:

• foot & ankle
• hip
• knee
• shoulder & elbow
• others

By distribution channel:

• hospitals
• pharmacies
• others

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global joint pain injection market report offers detailed information on several market vendors, including Anika Therapeutics, Inc., Bioventus Inc., Chugai Pharmaceutical Co., Ltd., Ferring B.V., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc., OrthogenRx, Inc., Sanofi S.A., SEIKAGAKU CORPORATION, Teva Pharmaceutical Industries Ltd., Zimmer Biomet Holdings Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global joint pain injection market.
• To classify and forecast the global joint pain injection market based on injection type, joint type, distribution channel, and region.
• To identify drivers and challenges for the global joint pain injection market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global joint pain injection market.
• To identify and analyze the profile of leading players operating in the global joint pain injection market.

Why Choose This Report

• Gain a reliable outlook of the global joint pain injection market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR JOINT PAIN INJECTION BY INJECTION TYPE

5.1 Corticosteroid
  5.1.1 Market size and forecast
5.2 Hyaluronic acid
  5.2.1 Market size and forecast
5.3 Others
  5.3.1 Market size and forecast

PART 6. GLOBAL MARKET FOR JOINT PAIN INJECTION BY JOINT TYPE

6.1 Foot & ankle
  6.1.1 Market size and forecast
6.2 Hip
  6.2.1 Market size and forecast
6.3 Knee
  6.3.1 Market size and forecast
6.4 Shoulder & elbow
  6.4.1 Market size and forecast
6.5 Others
  6.5.1 Market size and forecast

PART 7. GLOBAL MARKET FOR JOINT PAIN INJECTION BY DISTRIBUTION CHANNEL

7.1 Hospitals
  7.1.1 Market size and forecast
7.2 Pharmacies
  7.2.1 Market size and forecast
7.3 Others
  7.3.1 Market size and forecast

PART 8. GLOBAL MARKET FOR JOINT PAIN INJECTION BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Anika Therapeutics, Inc.
9.2 Bioventus Inc.
9.3 Chugai Pharmaceutical Co., Ltd.
9.4 Ferring B.V.
9.5 Fidia Farmaceutici s.p.a.
9.6 Flexion Therapeutics, Inc.
9.7 OrthogenRx, Inc.
9.8 Sanofi S.A.
9.9 SEIKAGAKU CORPORATION
9.10 Teva Pharmaceutical Industries Ltd.
9.11 Zimmer Biomet Holdings Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY